Clinical Trial Update: Pregabalin for Central Sensitization in TKA [Phase 4]

View source ↗

Summary

Clinical trial update shows a Phase 4 study of pregabalin for central sensitization in total knee arthroplasty has been terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: University of Iowa | Conditions: Osteo Arthritis Knee, Central Nervous System Sensitization | Phase 4 | Status: TERMINATED | Results posted: 2024-03-18